This cross-sectional analysis of data from December 8, 2022 to February 1, 2023 found that the association between serum CRP and Omicron variant COVID-19 pneumonia in cancer patients from China, which has certain guiding significance for the treatment and prognosis of cancer patients after contracting COVID-19. This evidence concerns the gene CRP and cancer.